Showing results (391-400 of 407) with videos related to
Sort By:
Pageof 41
Annals of the Rheumatic Diseases|August 12, 2010
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeDaniel Aletaha, Tuhina Neogi, Alan J Silman, et al.Journal of Translational Autoimmunity|January 1, 2024
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE studyChiara Tani, Chiara Cardelli, Roberto Depascale, et al.Arthritis and Rheumatism|February 13, 2013
Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitisMaria Apel, Steffen Uebe, John Bowes, et al.Arthritis and Rheumatism|September 28, 2010
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological reportTuhina Neogi, Daniel Aletaha, Alan J Silman, et al.Annals of the Rheumatic Diseases|March 18, 2024
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateLaure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, et al.Nature Genetics|October 19, 2010
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasisUlrike Hüffmeier, Steffen Uebe, Arif B Ekici, et al.Annals of the Rheumatic Diseases|May 14, 2015
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceJosef S Smolen, Ferdinand C Breedveld, Gerd R Burmester, et al.Therapeutic Advances in Musculoskeletal Disease|September 11, 2023
Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritisOliver FitzGerald, Frank Behrens, Anne Barton, et al.Nature Communications|February 6, 2015
Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritisJohn Bowes, Ashley Budu-Aggrey, Ulrike Huffmeier, et al.Clinical and Experimental Rheumatology|March 14, 2023
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody productsRosaria Talarico, Giuseppe Alvise Ramirez, Sofia C Barreira, et al.Pageof 41